← All diseases
Brain and nervous system
Frontotemporal dementia
Would you like to receive a message when there is new research about Frontotemporal dementia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was investigated — and you receive a notification as soon as there is new research on Frontotemporal dementia. View what Premium costs.
Publications and studies (1588)
- Musicality and social cognition in dementia: clinical and anatomical associations. (2024/12/13) ♡
- Frequency and neuropathology of HTT repeat expansions in FTD/ALS: co-existence rather than causation. (2024/12/12) ♡
- SUMO2 rescues neuronal and glial cells from the toxicity of P301L Tau mutant. (2024/12/12) ♡
- Artificial intelligence-based rapid brain volumetry substantially improves differential diagnosis in dementia. (2024/12/11) ♡
- C9orf72-linked arginine-rich dipeptide repeats aggravate pathological phase separation of G3BP1. (2024/12/10) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in a AAV- C9ORF72 (G 4 C 2) 66 mouse model. (2024/12/10) ♡
- Long-Term Multimodal Exercise Intervention for Patients with Frontotemporal Lobar Degeneration: Feasibility and Preliminary Outcomes. (2024/12/09) ♡
- A progranulin gene deletion in frontotemporal lobar degeneration with corticobasal syndrome in a TREDEM case report. (2024/12/08) ♡
- Liver enzyme and risk of vascular dementia: A univariable and multivariable Mendelian randomization of European descent. (2024/12/08) ♡
- RuvBL1/2 reduce toxic dipeptide repeat protein burden in multiple models of C9orf72-ALS/FTD. (2024/12/05) ♡
- Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsy. (2024/12/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Underestimated Role of Iron in Frontotemporal Dementia: A Narrative Review. (2024/12/03) ♡
- Exploring the Role of CCNF Variants in Italian ALS Patients. (2024/12/03) ♡
- Altered Empathy Processing in Frontotemporal Dementia. (2024/12/02) ♡
- Neuropsychiatric Symptoms Associated With Frontotemporal Atrophy in Older Adults Without Dementia. (2024/12/01) ♡
- Distinct Patterns of Socioemotional Dysfunction Relate to Aggressive Versus Nonaggressive Rule-breaking Antisocial Behaviors in Behavioral Variant Frontotemporal Dementia. (2024/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Diagnostic Challenges of Late-onset Neuropsychiatric Symptoms and Early-onset Dementia: A Clinical and Neuropathological Case Study. (2024/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Frontotemporal Dementia. (2024/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neuroimaging in Dementia. (2024/12/01) ♡
- Loss of function of VCP/TER94 causes neurodegeneration. (2024/12/01) ♡
- EEG-based classification of Alzheimer's disease and frontotemporal dementia: a comprehensive analysis of discriminative features. (2024/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Corticobasal degeneration: An update. (2024/11/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Use of Artificial Intelligence in Imaging Dementia. (2024/11/27) ♡
- Assessment of disease impact through health-related quality of life measurement in primary progressive aphasia. (2024/11/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Creativity and Mental Illness: A Case Study of a Patient with Progressive Bulbar Palsy. (2024/11/22) ♡
- SMART-PET: a Self-SiMilARiTy-aware generative adversarial framework for reconstructing low-count [18F]-FDG-PET brain imaging. (2024/11/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Memories and mimics: unveiling the potential of FDG-PET in guiding therapeutic approaches for neurodegenerative cognitive disorders. (2024/11/19) ♡
- Analysis of translatomic changes in the Ubqln2(P497S) model of ALS reveals that motor neurons express muscle-associated genes in non-disease states. (2024/11/19) ♡
- C9orf72 repeat expansion creates the unstable folate-sensitive fragile site FRA9A. (2024/11/12) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Pyridazine Compounds as NLRP3 Inhibitors for Treating Parkinson's Disease or Frontotemporal Dementia. (2024/11/07) ♡
- [Diagnosis, Notification, and Managements of ALS: A Personal Perspective from 40 years of Experience as a Clinical Neurologist]. (2024/11/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Generation and characterization of two induced pluripotent stem cell lines (ICGi052-A and ICGi052-B) from a patient with frontotemporal dementia with parkinsonism-17 associated with the pathological variant c.2013T>G in the MAPT gene. (2024/11/01) ♡
- Comparison of Serum and Cerebrospinal Fluid Neurofilament Light Chain Concentrations Measured by Ella™ and Lumipulse™ in Patients with Cognitive Impairment. (2024/10/29) ♡
- Plasma extracellular vesicle: a novel biomarker for neurodegenerative disease diagnosis. (2024/09/30) ♡
- A structural MRI marker predicts individual differences in impulsivity and classifies patients with behavioral-variant frontotemporal dementia from matched controls. (2024/09/16) ♡
- PML nuclear bodies: new players in familial amyotrophic lateral sclerosis-frontotemporal dementia? (2024/09/01) ♡
- Rescue of synaptosomal glutamate release defects in tau transgenic mice by the tau aggregation inhibitor hydromethylthionine. (2024/09/01) ♡
- Genetic evidence for causal association between migraine and dementia: a mendelian randomization study. (2024/07/05) ♡
- Mendelian Randomization Identifies Genetically Supported Drug Targets for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. (2024/07/01) ♡
- Neuronal conversion from glia to replenish the lost neurons. (2024/07/01) ♡
- Prevalence of and Factors Associated with Hypersexuality in Patients with Dementia: A Retrospective Cross-Sectional Study. (2024/07/01) ♡
- Artificial Intelligence Based Hierarchical Classification of Frontotemporal Dementia. (2024/07/01) ♡
- A Regression Framework for Predicting Cognitive Decline in Frontotemporal Dementia using Recurrent Neural Networks. (2024/07/01) ♡
- Role of pause duration in primary progressive aphasia. (2024/06/21) ♡
- The relationship between major depressive disorder and dementia: A bidirectional two-sample Mendelian randomization study. (2024/06/15) ♡
- The guaranteed euros: Probabilistic discounting in behavioural-variant frontotemporal dementia. (2024/06/01) ♡
- The lived experience of reconstructing identity in response to genetic risk of frontotemporal degeneration and amyotrophic lateral sclerosis. (2024/06/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer's disease (BenfoTeam). (2024/05/29) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Multifaceted genes in amyotrophic lateral sclerosis-frontotemporal dementia volume II. (2024/05/10) ♡
- Digital markers of motor speech impairments in spontaneous speech of patients with ALS-FTD spectrum disorders. (2024/05/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.